Is a complete VTGN research report available?

No complete published report is available for Vistagen Therapeutics, Inc. (VTGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · USD

$0.23

+0.00 (+0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VTGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.3M
Revenue (ttm)	1.3M
Net income (ttm)	-69.7M
EPS (ttm)	-$1.83
Shares out	41M
Volume	1,150,617
Beta	0.40
Price target	$1.00	+341.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -69.7M
EPS (ttm): -$1.83
Market cap: 9.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VTGN indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001411685
Company name	Vistagen Therapeutics, Inc.
Country	United States
Country code	US
Cusip	92840H400
Employees	41
Employees Change	-16%
Employees Change Percent	-28.07
Enterprise value	$-35.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US92840H4002
Last refreshed	2026-07-27
Market cap	$9.3M
Market cap category	Nano-Cap
Price	$0.23
Price currency	USD
Rev Per Employee	30,951.22x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	VTGN
Website	https://www.vistagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-750.13%
FCF yield	-716.78%
P/B ratio	0.25x
P/S ratio	7.32x
PS Forward	13.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5,683.69%
EBITDA Margin	-5,668.01%
Gross margin	100%
Gross Profit	$1.3M
Gross Profit Growth	161.11%
Gross Profit Growth5 Y	3.1%
Net Income	$-69.7M
Net Income Growth Years	0%
Pretax Margin	-5,490.78%
Profit Per Employee	$-1.7M
ROA	-67.84
Roa5y	-48.01
ROCE	-201.6
ROE	-131.6
Roe5y	-89.33
ROIC	-83.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-45.9%
Cagr15y	-44.38%
Cagr1y	-91.72%
Cagr3y	-50.43%
Cagr5y	-69.53%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	161.11x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth5 Y	3.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$48.6M
Cash	$45.4M
Current Assets	$46.9M
Current Liabilities	$12.8M
Debt	$1M
Debt Equity	$0.03
Equity	$35.5M
Liabilities	$13M
Long Term Assets	$1.6M
Long Term Liabilities	$249,000
Net Cash	$44.4M
Net Cash By Market Cap	$478
Net Cash Growth	-43.83%
Net Debt Equity	$-1.25
Tangible Book Value	$35.5M
Tangible Book Value Per Share	$0.9
WACC	5.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.67
Net Working Capital	$-10.5M
Quick ratio	3.55
Working Capital	$34.1M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.78%
1Y total return	-91.71%
200-day SMA	1.48
3Y total return	-87.83%
50-day SMA	0.48
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.74%
All Time High	1,890
All Time High Change	-99.99%
All Time High Date	2012-01-04
All Time Low	0.2
All Time Low Change	14.34%
All Time Low Date	2026-06-30
ATR	0.04
Beta	0.4
Beta1y	0.21
Beta2y	0.61
Ch YTD	-65.8
High	0.23
High52	5.14
High52 Date	2025-11-24
High52ch	-95.6%
Low	0.22
Low52	0.2
Low52 Date	2026-06-30
Low52ch	14.34%
Ma50ch	-53.26%
Premarket Change Percent	3.89
Premarket Price	$0.23
Premarket Volume	426
Price vs 200-day SMA	-84.65%
RSI	30.76
RSI Monthly	33.73
RSI Weekly	28.12
Sharpe ratio	-0.67x
Sortino ratio	-0.72
Total Return	-23.31%
Tr YTD	-65.8
Tr15y	-99.98%
Tr1m	-64.19%
Tr1w	-1.22%
Tr3m	-60.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$1
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.35
Earnings Revenue Estimate	166,670x
Earnings Revenue Estimate Growth	-31.69x
Operating Income	$-72.1M
Operating margin	-5,683.7
Price target	$1
Price Target Change	$342
Price Target Change Top	$342

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,040,461%
Float Percent	85.4%
Net Borrowing	95,000
Shares Insiders	0.47%
Shares Institutions	27.08%
Shares Out	41,032,453
Shares Qo Q	0.23%
Shares Yo Y	23.31%
Short Float	4.56%
Short Ratio	0.36
Short Shares	3.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-70.6M
Average Volume	4,305,468.35x
Bv Per Share	0.9
CAPEX	$-151,000
Ch10y	-99.78
Ch15y	-99.98
Ch1m	-64.19
Ch1w	-1.22
Ch1y	-91.71
Ch3m	-60.28
Ch3y	-87.83
Ch5y	-99.74
Ch6m	-64.93
Change	0.18%
Change From Open	1.52
Close	0.23
Days Gap	-1.33
Depreciation Amortization	199,000
Dollar Volume	260,499.7
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-72.1M
EBITDA	$-71.9M
EPS	$-1.83
F Score	2
FCF	$-66.6M
FCF EV Yield	189.87x
FCF Per Share	$-1.62
Financing CF	30,971,000
Fiscal Year End	March
Founded	1,998
Income Tax	$7,000
Investing CF	-877,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-15
Last Report Date	2026-03-31
Last Split Date	2023-06-07
Last Split Type	Reverse
Last10k Filing Date	2026-06-15
Ma150	0.57
Ma150ch	-60.44%
Ma20	0.29
Ma20ch	-21.58%
Net CF	-36,342,000
Next Earnings Date	2026-08-06
Open	0.22
Optionable	Yes
Position In Range	47.4
Post Close	0.23
Postmarket Change Percent	1.9
Postmarket Price	$0.23
Ppne	1,228,000
Pre Close	0.23
Price Date	2026-07-24
Ptbv Ratio	0.26
Relative Volume	0.27x
Revenue	1,269,000x
SBC By Revenue	314.97x
Share Based Comp	3,997,000
Tax By Revenue	0.55x
Tr6m	-64.93%
Us State	California
Volume	1,150,617
Z Score	-14.24

Vistagen Therapeutics, Inc. (VTGN)

Coverage state: Market snapshot only — no published research

Generate the first VTGN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VTGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VTGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VTGN

Frequently asked questions